Artículos de revistas
Load-induced Transcriptional Activation Of C-jun In Rat Myocardium: Regulation By Myocyte Enhancer Factor 2
Registro en:
Circulation Research. , v. 92, n. 2, p. 243 - 251, 2003.
97330
10.1161/01.RES.0000053184.94618.97
2-s2.0-0037423551
Autor
Nadruz Jr W.
Kobarg C.B.
Constancio S.S.
Corat P.D.C.
Franchini K.G.
Institución
Resumen
The increased expression of immediate-early genes is a key feature of the myocardial response to hypertrophic stimuli. In this study, we investigated whether pressure overload or phenylephrine treatment stimulated myocyte enhancer factor 2 (MEF2)-dependent transcriptional activation of c-jun in cardiac myocytes. Western blotting and immunohistochemical analysis of rat myocardium demonstrated that p70MEF2 is highly expressed in the rat heart and is predominantly located at the nuclei of cardiac myocytes. Electrophoretic mobility shift assays of myocardial nuclear extracts revealed a consistent DNA binding activation of MEF2 after 1 and 2 hours of pressure overload. We further showed that pressure overload induced a progressive nuclear translocation and activation of extracellular signalregulated kinase 5 (ERK5). Coimmunoprecipitation and in vitro kinase assays indicated that the activation of ERK5 was paralleled by increased association of ERK5/p70MEF2 and by enhanced ability of ERK5 to phosphorylate p70MEF2. Experiments with in vivo transfection of the left ventricle with the c-jun promoter reporter gene showed that pressure overload induced a consistent increase of c-jun transcriptional activity in the rat myocardium. Rendering the MEF2 site of the c-jun plasmid inactive by mutation abolished the load-induced activation of the c-jun promoter reporter gene. Mutation of the MEF2 site also abolished the phenylephrine-induced c-jun promoter activation in neonatal rat ventricular myocytes. In addition, we demonstrated that neonatal rat ventricular myocyte transfection with ERK5antisense oligodeoxynucleotide inhibited the phenylephrine-induced c-jun promoter activation. These findings identify MEF2 as a potential regulator of c-jun transactivation and suggest that ERK5 might be an important mediator of MEF2 and c-jun promoter activation in response to hypertrophic stimuli in cardiac myocytes. 92 2 243 251 Lorell, B.H., Carabello, B.A., Left ventricular hypertrophy: Pathogenesis, detection, and prognosis (2000) Circulation, 102, pp. 470-479 Komuro, I., Yazaki, Y., Control of cardiac gene expression by mechanical stress (1993) Annu Rev Physiol, 55, pp. 55-75 Sadoshima, J., Jahn, L., Takahashi, T., Kulik, T.J., Izumo, S., Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: An in vitro model of load-induced cardiac hypertrophy (1992) J Biol Chem, 267, pp. 10551-10560 Schunkert, H., Jahn, L., Izumo, S., Apstein, C.S., Lorell, B.H., Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts (1991) Proc Natl Acad Sci U S A, 88, pp. 11480-11484 Han, T.H., Lamph, W.W., Prywes, R., Mapping of epidermal growth factor-, serum-, and phorbol ester-responsive sequence elements in the c-jun promoter (1992) Mol Cell Biol, 12, pp. 4472-4477 Angel, P., Hattori, K., Smeal, T., Karin, M., The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 (1988) Cell, 55, pp. 875-885 Coso, O.A., Montaner, S., Fromm, C., Lacal, J.C., Prywes, R., Teramoto, H., Gutkind, J.S., Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor: Evidence for a novel c-jun amino-terminal kinase-independent pathway (1997) J Biol Chem, 272, pp. 20691-20697 Han, J., Jiang, Y., Li, Z., Kravchenko, V.V., Ulevitch, R.J., Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation (1997) Nature, 386, pp. 296-299 Molkentin, J.D., Markham, B.E., Myocyte-specific enhancer-binding factor (MEF-2) regulates α-cardiac myosin heavy chain gene expression in vitro and in vivo (1993) J Biol Chem, 268, pp. 19512-19520 Passier, R., Zeng, H., Frey, N., Naya, F.J., Nicol, R.L., McKinsey, T.A., Overbeek, P., Olson, E.N., CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo (2000) J Clin Invest, 105, pp. 1395-1406 Kolodziejczyk, S.M., Wang, L., Balazsi, K., DeRepentigny, Y., Kothary, R., Megeney, L.A., MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium (1999) Curr Biol, 9, pp. 1203-1206 Black, B.L., Olson, E.N., Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins (1998) Annu Rev Cell Dev Biol, 14, pp. 167-196 Glennon, P.E., Kaddoura, S., Sale, E.M., Sale, G.J., Fuller, S.J., Sugden, P.H., Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes (1996) Circ Res, 78, pp. 954-961 Abe, J., Takahashi, M., Ishida, M., Lee, J.D., Berk, B.C., c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (1997) J Biol Chem, 272, pp. 20389-20394 Domingos, P.P., Fonseca, P.M., Nadruz W., Jr., Franchini, K.G., Load-induced focal-adhesion kinase activation in the myocardium: Role of stretch and contractile activity (2002) Am J Physiol, 281, pp. H556-H564 Ferreri, N.R., An, S.-J., McGiff, J.C., Cyclooxygenase-2 expression and function in the medullary thick ascending limb (1999) Am J Physiol, 277, pp. F360-F368 Thai, M.V., Guruswamy, S., Cao, K.T., Pessin, J.E., Olson, A.L., Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice: Regulation of MEF2 DNA binding activity in insulin-deficient diabetes (1998) J Biol Chem, 273, pp. 14285-14292 Clarke, N., Arenzana, N., Hai, T., Minden, A., Prywes, R., Epidermal growth factor induction of the c-jun promoter by a Rac pathway (1998) Mol Cell Biol, 18, pp. 1065-1073 Marinissen, M.J., Chiariello, M., Pallante, M., Gutkind, J.S., A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: A role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5 (1999) Mol Cell Biol, 19, pp. 4289-4301 Han, J., Molkentin, J.D., Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology (2000) Trends Cardiovasc Med, 10, pp. 19-22 Yamazaki, T., Komuro, I., Yazaki, Y., Signaling pathways for cardiac hypertrophy (1998) Cell Signal, 10, pp. 693-698 Han, T.H., Prywes, R., Regulatory role of MEF2D in serum induction of the c-jun promoter (1995) Mol Cell Biol, 15, pp. 2907-2915 Kato, Y., Zhao, M., Morikawa, A., Sugiyama, T., Chakravortty, D., Koide, N., Yoshida, T., Lee, J.D., Big mitogen-activated kinase regulates multiple members of the MEF2 protein family (2000) J Biol Chem, 275, pp. 18534-18540 Suzuki, E., Nishimatsu, H., Satonaka, H., Walsh, K., Goto, A., Omata, M., Fujita, T., Hirata, Y., Angiotensin II induces myocyte enhancer factor 2and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes (2002) Circ Res, 90, pp. 1004-1011 Lu, J., McKinsey, T.A., Zhang, C.L., Olson, E.N., Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases (2000) Mol Cell, 6, pp. 233-244 Wu, H., Naya, F.J., McKinsey, T.A., Mercer, B., Shelton, J.M., Chin, E.R., Simard, A.R., Williams, E.S., MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type (2000) EMBO J, 19, pp. 1963-1973 Wang, Y., Huang, S., Sah, V.P., Ross J., Jr., Brown, J.H., Han, J., Chien, K.R., Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family (1998) J Biol Chem, 273, pp. 2161-2168 Nicol, R.L., Frey, N., Pearson, G., Cobb, M., Richardson, J., Olson, E.N., Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy (2001) EMBO J, 20, pp. 2757-2767 Sugden, P.H., Clerk, A., "Stress-responsive" mitogen-activated protein kinases (c-jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium (1998) Circ Res, 83, pp. 345-352 Fischer, T.A., Ludwig, S., Flory, E., Gambaryan, S., Singh, K., Finn, P., Pfeffer, M.A., Pfeffer, J.M., Activation of cardiac c-Jun NH2-terminal kinases and p38-mitogen-activated protein kinases with abrupt changes in hemodynamic load (2001) Hypertension, 37, pp. 1222-1228 Bogoyevitch, M.A., Gillespie-Brown, J., Ketterman, A.J., Fuller, S.J., Ben-Levy, R., Ashworth, A., Marshall, C.J., Sugden, P.H., Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion (1996) Circ Res, 79, pp. 162-173 Takeishi, Y., Abe, J., Lee, J.D., Kawakatsu, H., Walsh, R.A., Berk, B.C., Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts (1999) Circ Res, 85, pp. 1164-1172 Takeishi, Y., Huang, Q., Abe, J., Glassman, M., Che, W., Lee, J.D., Kawakatsu, H., Walsh, R.A., Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: Comparison with acute mechanical stretch (2001) J Mol Cell Cardiol, 33, pp. 1637-1648 Marinissen, M.J., Gutkind, J.S., G-protein-coupled receptors and signaling networks: Emerging paradigms (2001) Trends Pharmacol Sci, 22, pp. 368-376